Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation
- PMID: 25005789
- DOI: 10.1007/s00432-014-1772-6
Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation
Abstract
Malignant gliomas invariably recur after irradiation, showing radioresistance. Meanwhile, cranial irradiation can bring some risk for developing cognitive dysfunction. There is increasing evidence that cytokines play their peculiar roles in these processes. On the one hand, cytokines directly influence the progression of malignant glioma, promoting or suppressing tumor progression. On the other hand, cytokines indirectly contribute to the immunologic response against gliomas, exhibiting pro-inflammatory or immunosuppressive activities. We propose that cytokines are not simply unregulated products from tumor cells or immune cells, but mediators finely adjust the balance between glioma cells and tumor microenvironment after irradiation. The paper, therefore, focuses on the changes of cytokines after irradiation, analyzing how these mediate the response of tumor cells and normal cells to irradiation. In addition, cytokine-based immunotherapeutic strategies, accompanied with irradiation, for the treatment of gliomas are also discussed.
Similar articles
-
When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.Int J Mol Sci. 2018 Feb 1;19(2):436. doi: 10.3390/ijms19020436. Int J Mol Sci. 2018. PMID: 29389898 Free PMC article. Review.
-
Generation and immunologic functions of Th17 cells in malignant gliomas.Cancer Immunol Immunother. 2013 Jan;62(1):75-86. doi: 10.1007/s00262-012-1312-7. Epub 2012 Jul 1. Cancer Immunol Immunother. 2013. PMID: 22752645 Free PMC article.
-
Cytokine therapy.Adv Exp Med Biol. 2012;746:86-94. doi: 10.1007/978-1-4614-3146-6_7. Adv Exp Med Biol. 2012. PMID: 22639161 Review.
-
[The immunosuppressive microenvironment of malignant gliomas].Arkh Patol. 2015 Nov-Dec;77(6):54-63. doi: 10.17116/patol201577654-63. Arkh Patol. 2015. PMID: 26841651 Review. Russian.
-
Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.Front Immunol. 2018 Dec 21;9:2924. doi: 10.3389/fimmu.2018.02924. eCollection 2018. Front Immunol. 2018. PMID: 30619286 Free PMC article. Review.
Cited by
-
Caspase-4 in glioma indicates deterioration and unfavorable prognosis by affecting tumor cell proliferation and immune cell recruitment.Sci Rep. 2024 Jul 29;14(1):17443. doi: 10.1038/s41598-024-65018-z. Sci Rep. 2024. PMID: 39075190 Free PMC article.
-
Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.Cell Death Dis. 2020 Jun 25;11(6):485. doi: 10.1038/s41419-020-2696-5. Cell Death Dis. 2020. PMID: 32587256 Free PMC article. Review.
-
Inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, upregulated in glioblastoma multiforme, raise the levels of CRYAB in exosomes secreted by U373 glioma cells.Biochem Biophys Res Commun. 2014 Oct 24;453(3):326-31. doi: 10.1016/j.bbrc.2014.09.068. Epub 2014 Sep 26. Biochem Biophys Res Commun. 2014. PMID: 25261722 Free PMC article.
-
Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia.J Neurooncol. 2017 Jul;133(3):447-454. doi: 10.1007/s11060-017-2471-3. Epub 2017 May 17. J Neurooncol. 2017. PMID: 28516343 Review.
-
IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation.Radiat Oncol. 2015 Nov 14;10:227. doi: 10.1186/s13014-015-0534-1. Radiat Oncol. 2015. Retraction in: Radiat Oncol. 2022 May 16;17(1):96. doi: 10.1186/s13014-022-02030-5. PMID: 26572130 Free PMC article. Retracted.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical